Literature DB >> 23505081

Successful pneumonectomy for invasive pulmonary aspergillosis and advanced non-small cell-lung cancer.

Shohei Minesaki1, Nobuyuki Koyama, Hironori Ishida, Kunihiko Kobayashi.   

Abstract

Aspergillus spp. is a pathogenic fungus in patients with malignancy, immunosuppression or respiratory diseases, and invasive pulmonary aspergillosis (IPA) caused by its infection is an aggressive and often lethal disorder. We report a case of non-small-cell lung cancer (NSCLC) where pneumonectomy concomitantly enabled radical cure of the underlying disease and IPA against which different antifungal drugs had been ineffective. In a patient with locally advanced NSCLC that progressed despite chemoradiation, radiation pneumonitis and subsequently cavitary disease developed following the administration of corticosteroids. Based upon the isolation of Aspergillus spp. from sputum, a diagnosis of IPA was made and since the latter was refractory to multiple antifungal drugs, pneumonectomy was undertaken which resulted in successful treatment of both NSCLC and IPA. Surgical intervention should be considered as a therapeutic option for IPA complicating NSCLC that is refractory to medical management.

Entities:  

Mesh:

Year:  2013        PMID: 23505081      PMCID: PMC3618764          DOI: 10.1136/bcr-2012-007925

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  Host-dependent patterns of tissue injury in invasive pulmonary aspergillosis.

Authors:  Theodouli Stergiopoulou; Joseph Meletiadis; Emmanuel Roilides; David E Kleiner; R Schaufele; Maureen Roden; Susan Harrington; Luqman Dad; Brahm Segal; Thomas J Walsh
Journal:  Am J Clin Pathol       Date:  2007-03       Impact factor: 2.493

2.  Predicting outcome after lung resection for invasive pulmonary aspergillosis in patients with neutropenia.

Authors:  Peter Matt; Franziska Bernet; James Habicht; Franco Gambazzi; Alois Gratwohl; Hans-Reinhard Zerkowski; Michael Tamm
Journal:  Chest       Date:  2004-12       Impact factor: 9.410

Review 3.  Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease: an emerging fungal pathogen.

Authors:  F Ader; S Nseir; R Le Berre; S Leroy; I Tillie-Leblond; C H Marquette; A Durocher
Journal:  Clin Microbiol Infect       Date:  2005-06       Impact factor: 8.067

Review 4.  Sampling of Aspergillus spores in air.

Authors:  G Morris; M H Kokki; K Anderson; M D Richardson
Journal:  J Hosp Infect       Date:  2000-02       Impact factor: 3.926

5.  Surgical management of invasive pulmonary aspergillosis in immunocompromised patients.

Authors:  K Wong; C M Waters; R K Walesby
Journal:  Eur J Cardiothorac Surg       Date:  1992       Impact factor: 4.191

6.  A case of Aspergillus empyema successfully treated with combination therapy of voriconazole and micafungin: excellent penetration of voriconazole and micafungin into pleural fluid.

Authors:  Toshiaki Matsuda; Yoshimizu Koreeda; Hiroko Mataki; Tetsuhiko Taira; Satoshi Noma; Ikkou Higashimoto
Journal:  Intern Med       Date:  2010-06-15       Impact factor: 1.271

7.  Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: benefits of intensive care?

Authors:  P A Bulpa; A M Dive; M G Garrino; M A Delos; M R Gonzalez; P A Evrard; Y Glupczynski; E J Installé
Journal:  Intensive Care Med       Date:  2001-01       Impact factor: 17.440

8.  Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.

Authors:  Raoul Herbrecht; David W Denning; Thomas F Patterson; John E Bennett; Reginald E Greene; Jörg-W Oestmann; Winfried V Kern; Kieren A Marr; Patricia Ribaud; Olivier Lortholary; Richard Sylvester; Robert H Rubin; John R Wingard; Paul Stark; Christine Durand; Denis Caillot; Eckhard Thiel; Pranatharthi H Chandrasekar; Michael R Hodges; Haran T Schlamm; Peter F Troke; Ben de Pauw
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

9.  Invasive aspergillosis in critically ill patients without malignancy.

Authors:  Wouter Meersseman; Stefaan J Vandecasteele; Alexander Wilmer; Eric Verbeken; Willy E Peetermans; Eric Van Wijngaerden
Journal:  Am J Respir Crit Care Med       Date:  2004-06-30       Impact factor: 21.405

10.  Pathogenesis of pulmonary aspergillosis. Granulocytopenia versus cyclosporine and methylprednisolone-induced immunosuppression.

Authors:  J Berenguer; M C Allende; J W Lee; K Garrett; C Lyman; N M Ali; J Bacher; P A Pizzo; T J Walsh
Journal:  Am J Respir Crit Care Med       Date:  1995-09       Impact factor: 21.405

View more
  1 in total

1.  Aspergillus spp. colonization in exhaled breath condensate of lung cancer patients from Puglia Region of Italy.

Authors:  Giovanna E Carpagnano; Donato Lacedonia; Grazia Pia Palladino; Giuseppe Logrieco; Elisabetta Crisetti; Antonia Susca; Antonio Logrieco; Maria P Foschino-Barbaro
Journal:  BMC Pulm Med       Date:  2014-02-18       Impact factor: 3.317

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.